Louisiana State Employees Retirement System Vir Biotechnology, Inc. Transaction History
Louisiana State Employees Retirement System
- $5.33 Billion
- Q3 2024
A detailed history of Louisiana State Employees Retirement System transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 44,300 shares of VIR stock, worth $470,909. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,300
Previous 43,800
1.14%
Holding current value
$470,909
Previous $389,000
14.91%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding VIR
# of Institutions
215Shares Held
87MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$177 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$175 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$140 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$59.8 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$38 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.41B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...